The role of MyoD1 and histone modifications in the activation of muscle enhancers

References

• Ong CT, Corces VG. Enhancer function: new insights into the regulation of tissue-specific gene expression. Nat Rev Genet 2011; 12:283 - 93; http://dx.doi.org/10.1038/nrg2957; PMID: 21358745
   PubMed Web of Science ®Google Scholar
• Bulger M, Groudine M. Functional and mechanistic diversity of distal transcription enhancers. Cell 2011; 144:327 - 39; http://dx.doi.org/10.1016/j.cell.2011.01.024; PMID: 21295696
   PubMed Web of Science ®Google Scholar
• Spitz F, Furlong EE. Transcription factors: from enhancer binding to developmental control. Nat Rev Genet 2012; 13:613 - 26; http://dx.doi.org/10.1038/nrg3207; PMID: 22868264
   PubMed Web of Science ®Google Scholar
• Calo E, Wysocka J. Modification of enhancer chromatin: what, how, and why?. Mol Cell 2013; 49:825 - 37; http://dx.doi.org/10.1016/j.molcel.2013.01.038; PMID: 23473601
   PubMed Web of Science ®Google Scholar
• Heintzman ND, Hon GC, Hawkins RD, Kheradpour P, Stark A, Harp LF, et al. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 2009; 459:108 - 12; http://dx.doi.org/10.1038/nature07829; PMID: 19295514
   PubMed Web of Science ®Google Scholar
• Visel A, Blow MJ, Li Z, Zhang T, Akiyama JA, Holt A, et al. ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature 2009; 457:854 - 8; http://dx.doi.org/10.1038/nature07730; PMID: 19212405
   PubMed Web of Science ®Google Scholar
• Cui K, Zang C, Roh TY, Schones DE, Childs RW, Peng W, et al. Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent genes during differentiation. Cell Stem Cell 2009; 4:80 - 93; http://dx.doi.org/10.1016/j.stem.2008.11.011; PMID: 19128795
   PubMed Web of Science ®Google Scholar
• Creyghton MP, Cheng AW, Welstead GG, Kooistra T, Carey BW, Steine EJ, et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci U S A 2010; 107:21931 - 6; http://dx.doi.org/10.1073/pnas.1016071107; PMID: 21106759
   PubMed Web of Science ®Google Scholar
• Blackwood EM, Kadonaga JT. Going the distance: a current view of enhancer action. Science 1998; 281:60 - 3; http://dx.doi.org/10.1126/science.281.5373.60; PMID: 9679020
   PubMed Web of Science ®Google Scholar
• Chepelev I, Wei G, Wangsa D, Tang Q, Zhao K. Characterization of genome-wide enhancer-promoter interactions reveals co-expression of interacting genes and modes of higher order chromatin organization. Cell Res 2012; 22:490 - 503; http://dx.doi.org/10.1038/cr.2012.15; PMID: 22270183
   PubMed Web of Science ®Google Scholar
• Akhtar-Zaidi B, Cowper-Sal-lari R, Corradin O, Saiakhova A, Bartels CF, Balasubramanian D, et al. Epigenomic enhancer profiling defines a signature of colon cancer. Science 2012; 336:736 - 9; http://dx.doi.org/10.1126/science.1217277; PMID: 22499810
   PubMed Web of Science ®Google Scholar
• Emison ES, McCallion AS, Kashuk CS, Bush RT, Grice E, Lin S, et al. A common sex-dependent mutation in a RET enhancer underlies Hirschsprung disease risk. Nature 2005; 434:857 - 63; http://dx.doi.org/10.1038/nature03467; PMID: 15829955
   PubMed Web of Science ®Google Scholar
• Kleinjan DA, van Heyningen V. Long-range control of gene expression: emerging mechanisms and disruption in disease. Am J Hum Genet 2005; 76:8 - 32; http://dx.doi.org/10.1086/426833; PMID: 15549674
   PubMed Web of Science ®Google Scholar
• Visel A, Rubin EM, Pennacchio LA. Genomic views of distant-acting enhancers. Nature 2009; 461:199 - 205; http://dx.doi.org/10.1038/nature08451; PMID: 19741700
   PubMed Web of Science ®Google Scholar
• Noonan JP, McCallion AS. Genomics of long-range regulatory elements. Annu Rev Genomics Hum Genet 2010; 11:1 - 23; http://dx.doi.org/10.1146/annurev-genom-082509-141651; PMID: 20438361
   PubMed Web of Science ®Google Scholar
• van den Boogaard M, Wong LY, Tessadori F, Bakker ML, Dreizehnter LK, Wakker V, et al. Genetic variation in T-box binding element functionally affects SCN5A/SCN10A enhancer. J Clin Invest 2012; 122:2519 - 30; http://dx.doi.org/10.1172/JCI62613; PMID: 22706305
   PubMed Web of Science ®Google Scholar
• Visser M, Kayser M, Palstra RJ. HERC2 rs12913832 modulates human pigmentation by attenuating chromatin-loop formation between a long-range enhancer and the OCA2 promoter. Genome Res 2012; 22:446 - 55; http://dx.doi.org/10.1101/gr.128652.111; PMID: 22234890
   PubMed Web of Science ®Google Scholar
• Heintzman ND, Stuart RK, Hon G, Fu Y, Ching CW, Hawkins RD, et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet 2007; 39:311 - 8; http://dx.doi.org/10.1038/ng1966; PMID: 17277777
   PubMed Web of Science ®Google Scholar
• Zentner GE, Tesar PJ, Scacheri PC. Epigenetic signatures distinguish multiple classes of enhancers with distinct cellular functions. Genome Res 2011; 21:1273 - 83; http://dx.doi.org/10.1101/gr.122382.111; PMID: 21632746
   PubMed Web of Science ®Google Scholar
• Kim TK, Hemberg M, Gray JM, Costa AM, Bear DM, Wu J, et al. Widespread transcription at neuronal activity-regulated enhancers. Nature 2010; 465:182 - 7; http://dx.doi.org/10.1038/nature09033; PMID: 20393465
   PubMed Web of Science ®Google Scholar
• De Santa F, Barozzi I, Mietton F, Ghisletti S, Polletti S, Tusi BK, et al. A large fraction of extragenic RNA pol II transcription sites overlap enhancers. PLoS Biol 2010; 8:e1000384; http://dx.doi.org/10.1371/journal.pbio.1000384; PMID: 20485488
   PubMed Web of Science ®Google Scholar
• Visel A, Taher L, Girgis H, May D, Golonzhka O, Hoch RV, et al. A high-resolution enhancer atlas of the developing telencephalon. Cell 2013; 152:895 - 908; http://dx.doi.org/10.1016/j.cell.2012.12.041; PMID: 23375746
   PubMed Web of Science ®Google Scholar
• Ghisletti S, Barozzi I, Mietton F, Polletti S, De Santa F, Venturini E, et al. Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages. Immunity 2010; 32:317 - 28; http://dx.doi.org/10.1016/j.immuni.2010.02.008; PMID: 20206554
   PubMed Web of Science ®Google Scholar
• May D, Blow MJ, Kaplan T, McCulley DJ, Jensen BC, Akiyama JA, et al. Large-scale discovery of enhancers from human heart tissue. Nat Genet 2012; 44:89 - 93; http://dx.doi.org/10.1038/ng.1006; PMID: 22138689
   PubMed Web of Science ®Google Scholar
• Narlikar L, Sakabe NJ, Blanski AA, Arimura FE, Westlund JM, Nobrega MA, et al. Genome-wide discovery of human heart enhancers. Genome Res 2010; 20:381 - 92; http://dx.doi.org/10.1101/gr.098657.109; PMID: 20075146
   PubMed Web of Science ®Google Scholar
• Mikkelsen TS, Xu Z, Zhang X, Wang L, Gimble JM, Lander ES, et al. Comparative epigenomic analysis of murine and human adipogenesis. Cell 2010; 143:156 - 69; http://dx.doi.org/10.1016/j.cell.2010.09.006; PMID: 20887899
   PubMed Web of Science ®Google Scholar
• Xu J, Watts JA, Pope SD, Gadue P, Kamps M, Plath K, et al. Transcriptional competence and the active marking of tissue-specific enhancers by defined transcription factors in embryonic and induced pluripotent stem cells. Genes Dev 2009; 23:2824 - 38; http://dx.doi.org/10.1101/gad.1861209; PMID: 20008934
   PubMed Web of Science ®Google Scholar
• Vahedi G, Takahashi H, Nakayamada S, Sun HW, Sartorelli V, Kanno Y, et al. STATs shape the active enhancer landscape of T cell populations. Cell 2012; 151:981 - 93; http://dx.doi.org/10.1016/j.cell.2012.09.044; PMID: 23178119
   PubMed Web of Science ®Google Scholar
• Ostuni R, Piccolo V, Barozzi I, Polletti S, Termanini A, Bonifacio S, et al. Latent enhancers activated by stimulation in differentiated cells. Cell 2013; 152:157 - 71; http://dx.doi.org/10.1016/j.cell.2012.12.018; PMID: 23332752
   PubMed Web of Science ®Google Scholar
• Rada-Iglesias A, Bajpai R, Swigut T, Brugmann SA, Flynn RA, Wysocka J. A unique chromatin signature uncovers early developmental enhancers in humans. Nature 2011; 470:279 - 83; http://dx.doi.org/10.1038/nature09692; PMID: 21160473
   PubMed Web of Science ®Google Scholar
• Bogdanovic O, Fernandez-Miñán A, Tena JJ, de la Calle-Mustienes E, Hidalgo C, van Kruysbergen I, et al. Dynamics of enhancer chromatin signatures mark the transition from pluripotency to cell specification during embryogenesis. Genome Res 2012; 22:2043 - 53; http://dx.doi.org/10.1101/gr.134833.111; PMID: 22593555
   PubMed Web of Science ®Google Scholar
• Asp P, Blum R, Vethantham V, Parisi F, Micsinai M, Cheng J, et al. Genome-wide remodeling of the epigenetic landscape during myogenic differentiation. Proc Natl Acad Sci U S A 2011; 108:E149 - 58; http://dx.doi.org/10.1073/pnas.1102223108; PMID: 21551099
   PubMed Web of Science ®Google Scholar
• Zaret KS, Carroll JS. Pioneer transcription factors: establishing competence for gene expression. Genes Dev 2011; 25:2227 - 41; http://dx.doi.org/10.1101/gad.176826.111; PMID: 22056668
   PubMed Web of Science ®Google Scholar
• Bergsland M, Ramsköld D, Zaouter C, Klum S, Sandberg R, Muhr J. Sequentially acting Sox transcription factors in neural lineage development. Genes Dev 2011; 25:2453 - 64; http://dx.doi.org/10.1101/gad.176008.111; PMID: 22085726
   PubMed Web of Science ®Google Scholar
• Tapscott SJ. The circuitry of a master switch: Myod and the regulation of skeletal muscle gene transcription. Development 2005; 132:2685 - 95; http://dx.doi.org/10.1242/dev.01874; PMID: 15930108
   PubMed Web of Science ®Google Scholar
• Rudnicki MA, Schnegelsberg PN, Stead RH, Braun T, Arnold HH, Jaenisch R. MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 1993; 75:1351 - 9; http://dx.doi.org/10.1016/0092-8674(93)90621-V; PMID: 8269513
   PubMed Web of Science ®Google Scholar
• Davis RL, Weintraub H, Lassar AB. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 1987; 51:987 - 1000; http://dx.doi.org/10.1016/0092-8674(87)90585-X; PMID: 3690668
   PubMed Web of Science ®Google Scholar
• Weintraub H, Tapscott SJ, Davis RL, Thayer MJ, Adam MA, Lassar AB, et al. Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. Proc Natl Acad Sci U S A 1989; 86:5434 - 8; http://dx.doi.org/10.1073/pnas.86.14.5434; PMID: 2748593
   PubMed Web of Science ®Google Scholar
• Lassar AB, Davis RL, Wright WE, Kadesch T, Murre C, Voronova A, et al. Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo. Cell 1991; 66:305 - 15; http://dx.doi.org/10.1016/0092-8674(91)90620-E; PMID: 1649701
   PubMed Web of Science ®Google Scholar
• Bergstrom DA, Penn BH, Strand A, Perry RL, Rudnicki MA, Tapscott SJ. Promoter-specific regulation of MyoD binding and signal transduction cooperate to pattern gene expression. Mol Cell 2002; 9:587 - 600; http://dx.doi.org/10.1016/S1097-2765(02)00481-1; PMID: 11931766
   PubMed Web of Science ®Google Scholar
• Murre C, McCaw PS, Vaessin H, Caudy M, Jan LY, Jan YN, et al. Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell 1989; 58:537 - 44; http://dx.doi.org/10.1016/0092-8674(89)90434-0; PMID: 2503252
   PubMed Web of Science ®Google Scholar
• Blackwell TK, Weintraub H. Differences and similarities in DNA-binding preferences of MyoD and E2A protein complexes revealed by binding site selection. Science 1990; 250:1104 - 10; http://dx.doi.org/10.1126/science.2174572; PMID: 2174572
   PubMed Web of Science ®Google Scholar
• Blais A, Tsikitis M, Acosta-Alvear D, Sharan R, Kluger Y, Dynlacht BD. An initial blueprint for myogenic differentiation. Genes Dev 2005; 19:553 - 69; http://dx.doi.org/10.1101/gad.1281105; PMID: 15706034
   PubMed Web of Science ®Google Scholar
• Cao Y, Yao Z, Sarkar D, Lawrence M, Sanchez GJ, Parker MH, et al. Genome-wide MyoD binding in skeletal muscle cells: a potential for broad cellular reprogramming. Dev Cell 2010; 18:662 - 74; http://dx.doi.org/10.1016/j.devcel.2010.02.014; PMID: 20412780
   PubMed Web of Science ®Google Scholar
• Davis RL, Weintraub H. Acquisition of myogenic specificity by replacement of three amino acid residues from MyoD into E12. Science 1992; 256:1027 - 30; http://dx.doi.org/10.1126/science.1317057; PMID: 1317057
   PubMed Web of Science ®Google Scholar
• Bengal E, Flores O, Rangarajan PN, Chen A, Weintraub H, Verma IM. Positive control mutations in the MyoD basic region fail to show cooperative DNA binding and transcriptional activation in vitro. Proc Natl Acad Sci U S A 1994; 91:6221 - 5; http://dx.doi.org/10.1073/pnas.91.13.6221; PMID: 8016142
   PubMed Web of Science ®Google Scholar
• Dilworth FJ, Seaver KJ, Fishburn AL, Htet SL, Tapscott SJ. In vitro transcription system delineates the distinct roles of the coactivators pCAF and p300 during MyoD/E47-dependent transactivation. Proc Natl Acad Sci U S A 2004; 101:11593 - 8; http://dx.doi.org/10.1073/pnas.0404192101; PMID: 15289617
   PubMed Web of Science ®Google Scholar
• Yee SP, Rigby PW. The regulation of myogenin gene expression during the embryonic development of the mouse. Genes Dev 1993; 7:7A 1277 - 89; http://dx.doi.org/10.1101/gad.7.7a.1277; PMID: 8391506
   PubMed Web of Science ®Google Scholar
• Cheng TC, Wallace MC, Merlie JP, Olson EN. Separable regulatory elements governing myogenin transcription in mouse embryogenesis. Science 1993; 261:215 - 8; http://dx.doi.org/10.1126/science.8392225; PMID: 8392225
   PubMed Web of Science ®Google Scholar
• Goldhamer DJ, Brunk BP, Faerman A, King A, Shani M, Emerson CP Jr.. Embryonic activation of the myoD gene is regulated by a highly conserved distal control element. Development 1995; 121:637 - 49; PMID: 7720572
   PubMed Web of Science ®Google Scholar
• Donoghue M, Ernst H, Wentworth B, Nadal-Ginard B, Rosenthal N. A muscle-specific enhancer is located at the 3′ end of the myosin light-chain 1/3 gene locus. Genes Dev 1988; 2:12B 1779 - 90; http://dx.doi.org/10.1101/gad.2.12b.1779; PMID: 3240859
   PubMedGoogle Scholar
• Rosenthal N, Berglund EB, Wentworth BM, Donoghue M, Winter B, Bober E, et al. A highly conserved enhancer downstream of the human MLC1/3 locus is a target for multiple myogenic determination factors. Nucleic Acids Res 1990; 18:6239 - 46; http://dx.doi.org/10.1093/nar/18.21.6239; PMID: 2243772
   PubMed Web of Science ®Google Scholar
• Wentworth BM, Donoghue M, Engert JC, Berglund EB, Rosenthal N. Paired MyoD-binding sites regulate myosin light chain gene expression. Proc Natl Acad Sci U S A 1991; 88:1242 - 6; http://dx.doi.org/10.1073/pnas.88.4.1242; PMID: 1847512
   PubMed Web of Science ®Google Scholar
• Johnson JE, Wold BJ, Hauschka SD. Muscle creatine kinase sequence elements regulating skeletal and cardiac muscle expression in transgenic mice. Mol Cell Biol 1989; 9:3393 - 9; PMID: 2796990
   PubMed Web of Science ®Google Scholar
• Horlick RA, Benfield PA. The upstream muscle-specific enhancer of the rat muscle creatine kinase gene is composed of multiple elements. Mol Cell Biol 1989; 9:2396 - 413; PMID: 2761536
   PubMed Web of Science ®Google Scholar
• Carvajal JJ, Keith A, Rigby PW. Global transcriptional regulation of the locus encoding the skeletal muscle determination genes Mrf4 and Myf5. Genes Dev 2008; 22:265 - 76; http://dx.doi.org/10.1101/gad.442408; PMID: 18198342
   PubMed Web of Science ®Google Scholar
• Chang TH, Primig M, Hadchouel J, Tajbakhsh S, Rocancourt D, Fernandez A, et al. An enhancer directs differential expression of the linked Mrf4 and Myf5 myogenic regulatory genes in the mouse. Dev Biol 2004; 269:595 - 608; http://dx.doi.org/10.1016/j.ydbio.2004.02.013; PMID: 15110722
   PubMed Web of Science ®Google Scholar
• Wakabayashi-Takai E, Noguchi S, Ozawa E. Identification of myogenesis-dependent transcriptional enhancers in promoter region of mouse gamma-sarcoglycan gene. Eur J Biochem 2001; 268:948 - 57; http://dx.doi.org/10.1046/j.1432-1327.2001.01954.x; PMID: 11179961
   PubMedGoogle Scholar
• Tournay O, Benezra R. Transcription of the dominant-negative helix-loop-helix protein Id1 is regulated by a protein complex containing the immediate-early response gene Egr-1. Mol Cell Biol 1996; 16:2418 - 30; PMID: 8628310
   PubMed Web of Science ®Google Scholar
• Barthel KK, Liu X. A transcriptional enhancer from the coding region of ADAMTS5. PLoS One 2008; 3:e2184; http://dx.doi.org/10.1371/journal.pone.0002184; PMID: 18478108
   PubMedGoogle Scholar
• Blum R, Vethantham V, Bowman C, Rudnicki M, Dynlacht BD. Genome-wide identification of enhancers in skeletal muscle: the role of MyoD1. Genes Dev 2012; 26:2763 - 79; http://dx.doi.org/10.1101/gad.200113.112; PMID: 23249738
   PubMed Web of Science ®Google Scholar
• Ponting CP. The functional repertoires of metazoan genomes. Nat Rev Genet 2008; 9:689 - 98; http://dx.doi.org/10.1038/nrg2413; PMID: 18663365
   PubMed Web of Science ®Google Scholar
• Prabhakar S, Poulin F, Shoukry M, Afzal V, Rubin EM, Couronne O, et al. Close sequence comparisons are sufficient to identify human cis-regulatory elements. Genome Res 2006; 16:855 - 63; http://dx.doi.org/10.1101/gr.4717506; PMID: 16769978
   PubMed Web of Science ®Google Scholar
• Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van Baren MJ, et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 2010; 28:511 - 5; http://dx.doi.org/10.1038/nbt.1621; PMID: 20436464
   PubMed Web of Science ®Google Scholar
• Ostrovsky O, Bengal E, Aronheim A. Induction of terminal differentiation by the c-Jun dimerization protein JDP2 in C2 myoblasts and rhabdomyosarcoma cells. J Biol Chem 2002; 277:40043 - 54; http://dx.doi.org/10.1074/jbc.M205494200; PMID: 12171923
   PubMed Web of Science ®Google Scholar
• Knoepfler PS, Bergstrom DA, Uetsuki T, Dac-Korytko I, Sun YH, Wright WE, et al. A conserved motif N-terminal to the DNA-binding domains of myogenic bHLH transcription factors mediates cooperative DNA binding with pbx-Meis1/Prep1. Nucleic Acids Res 1999; 27:3752 - 61; http://dx.doi.org/10.1093/nar/27.18.3752; PMID: 10471746
   PubMed Web of Science ®Google Scholar
• Bengal E, Ransone L, Scharfmann R, Dwarki VJ, Tapscott SJ, Weintraub H, et al. Functional antagonism between c-Jun and MyoD proteins: a direct physical association. Cell 1992; 68:507 - 19; http://dx.doi.org/10.1016/0092-8674(92)90187-H; PMID: 1310896
   PubMed Web of Science ®Google Scholar
• Wang X, Blagden C, Fan J, Nowak SJ, Taniuchi I, Littman DR, et al. Runx1 prevents wasting, myofibrillar disorganization, and autophagy of skeletal muscle. Genes Dev 2005; 19:1715 - 22; http://dx.doi.org/10.1101/gad.1318305; PMID: 16024660
   PubMed Web of Science ®Google Scholar
• Puri PL, Sartorelli V, Yang XJ, Hamamori Y, Ogryzko VV, Howard BH, et al. Differential roles of p300 and PCAF acetyltransferases in muscle differentiation. Mol Cell 1997; 1:35 - 45; http://dx.doi.org/10.1016/S1097-2765(00)80005-2; PMID: 9659901
   PubMed Web of Science ®Google Scholar
• Rampalli S, Li L, Mak E, Ge K, Brand M, Tapscott SJ, et al. p38 MAPK signaling regulates recruitment of Ash2L-containing methyltransferase complexes to specific genes during differentiation. Nat Struct Mol Biol 2007; 14:1150 - 6; http://dx.doi.org/10.1038/nsmb1316; PMID: 18026121
   PubMed Web of Science ®Google Scholar
• Simone C, Forcales SV, Hill DA, Imbalzano AN, Latella L, Puri PL. p38 pathway targets SWI-SNF chromatin-remodeling complex to muscle-specific loci. Nat Genet 2004; 36:738 - 43; http://dx.doi.org/10.1038/ng1378; PMID: 15208625
   PubMed Web of Science ®Google Scholar
• Cao Y, Kumar RM, Penn BH, Berkes CA, Kooperberg C, Boyer LA, et al. Global and gene-specific analyses show distinct roles for Myod and Myog at a common set of promoters. EMBO J 2006; 25:502 - 11; http://dx.doi.org/10.1038/sj.emboj.7600958; PMID: 16437161
   PubMed Web of Science ®Google Scholar
• Yuan W, Condorelli G, Caruso M, Felsani A, Giordano A. Human p300 protein is a coactivator for the transcription factor MyoD. J Biol Chem 1996; 271:9009 - 13; http://dx.doi.org/10.1074/jbc.271.15.9009; PMID: 8621548
   PubMed Web of Science ®Google Scholar
• Sartorelli V, Puri PL, Hamamori Y, Ogryzko V, Chung G, Nakatani Y, et al. Acetylation of MyoD directed by PCAF is necessary for the execution of the muscle program. Mol Cell 1999; 4:725 - 34; http://dx.doi.org/10.1016/S1097-2765(00)80383-4; PMID: 10619020
   PubMed Web of Science ®Google Scholar
• Tao Y, Neppl RL, Huang ZP, Chen J, Tang RH, Cao R, et al. The histone methyltransferase Set7/9 promotes myoblast differentiation and myofibril assembly. J Cell Biol 2011; 194:551 - 65; http://dx.doi.org/10.1083/jcb.201010090; PMID: 21859860
   PubMed Web of Science ®Google Scholar
• Ludolph DC, Konieczny SF. Transcription factor families: muscling in on the myogenic program. FASEB J 1995; 9:1595 - 604; PMID: 8529839
   PubMed Web of Science ®Google Scholar
• Wang JC, Waltner-Law M, Yamada K, Osawa H, Stifani S, Granner DK. Transducin-like enhancer of split proteins, the human homologs of Drosophila groucho, interact with hepatic nuclear factor 3beta. J Biol Chem 2000; 275:18418 - 23; http://dx.doi.org/10.1074/jbc.M910211199; PMID: 10748198
   PubMed Web of Science ®Google Scholar
• Sekiya T, Zaret KS. Repression by Groucho/TLE/Grg proteins: genomic site recruitment generates compacted chromatin in vitro and impairs activator binding in vivo. Mol Cell 2007; 28:291 - 303; http://dx.doi.org/10.1016/j.molcel.2007.10.002; PMID: 17964267
   PubMed Web of Science ®Google Scholar
• Chargé SB, Rudnicki MA. Cellular and molecular regulation of muscle regeneration. Physiol Rev 2004; 84:209 - 38; http://dx.doi.org/10.1152/physrev.00019.2003; PMID: 14715915
   PubMed Web of Science ®Google Scholar
• Lluís F, Ballestar E, Suelves M, Esteller M, Muñoz-Cánoves P. E47 phosphorylation by p38 MAPK promotes MyoD/E47 association and muscle-specific gene transcription. EMBO J 2005; 24:974 - 84; http://dx.doi.org/10.1038/sj.emboj.7600528; PMID: 15719023
   PubMed Web of Science ®Google Scholar
• Ornatsky OI, Cox DM, Tangirala P, Andreucci JJ, Quinn ZA, Wrana JL, et al. Post-translational control of the MEF2A transcriptional regulatory protein. Nucleic Acids Res 1999; 27:2646 - 54; http://dx.doi.org/10.1093/nar/27.13.2646; PMID: 10373581
   PubMed Web of Science ®Google Scholar
• Zhao M, New L, Kravchenko VV, Kato Y, Gram H, di Padova F, et al. Regulation of the MEF2 family of transcription factors by p38. Mol Cell Biol 1999; 19:21 - 30; PMID: 9858528
   PubMed Web of Science ®Google Scholar
• Puri PL, Wu Z, Zhang P, Wood LD, Bhakta KS, Han J, et al. Induction of terminal differentiation by constitutive activation of p38 MAP kinase in human rhabdomyosarcoma cells. Genes Dev 2000; 14:574 - 84; PMID: 10716945
   PubMed Web of Science ®Google Scholar
• Black BL, Olson EN. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu Rev Cell Dev Biol 1998; 14:167 - 96; http://dx.doi.org/10.1146/annurev.cellbio.14.1.167; PMID: 9891782
   PubMed Web of Science ®Google Scholar
• Gillespie MA, Le Grand F, Scimè A, Kuang S, von Maltzahn J, Seale V, et al. p38-gamma-dependent gene silencing restricts entry into the myogenic differentiation program. J Cell Biol 2009; 187:991 - 1005; http://dx.doi.org/10.1083/jcb.200907037; PMID: 20026657
   PubMed Web of Science ®Google Scholar
• Wu Z, Woodring PJ, Bhakta KS, Tamura K, Wen F, Feramisco JR, et al. p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps. Mol Cell Biol 2000; 20:3951 - 64; http://dx.doi.org/10.1128/MCB.20.11.3951-3964.2000; PMID: 10805738
   PubMed Web of Science ®Google Scholar
• Lawlor MA, Rotwein P. Insulin-like growth factor-mediated muscle cell survival: central roles for Akt and cyclin-dependent kinase inhibitor p21. Mol Cell Biol 2000; 20:8983 - 95; http://dx.doi.org/10.1128/MCB.20.23.8983-8995.2000; PMID: 11073997
   PubMed Web of Science ®Google Scholar
• Musarò A, McCullagh K, Paul A, Houghton L, Dobrowolny G, Molinaro M, et al. Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat Genet 2001; 27:195 - 200; http://dx.doi.org/10.1038/84839; PMID: 11175789
   PubMed Web of Science ®Google Scholar
• Barton ER, Morris L, Musaro A, Rosenthal N, Sweeney HL. Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice. J Cell Biol 2002; 157:137 - 48; http://dx.doi.org/10.1083/jcb.200108071; PMID: 11927606
   PubMed Web of Science ®Google Scholar
• Serra C, Palacios D, Mozzetta C, Forcales SV, Morantte I, Ripani M, et al. Functional interdependence at the chromatin level between the MKK6/p38 and IGF1/PI3K/AKT pathways during muscle differentiation. Mol Cell 2007; 28:200 - 13; http://dx.doi.org/10.1016/j.molcel.2007.08.021; PMID: 17964260
   PubMed Web of Science ®Google Scholar